Recall StatusOpen, Classified
Date Initiated2026-05-01
Product Quantity424 units
Reason for Recall
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Firm Action
On May 1, 2026, InspireMD, Inc. issued a Urgent Medical Device Recall notification to affected consignees. InspireMD asked consignees to take the following actions:
1. Cease further use of all affected CGuard Prime Carotid Stent Systems identified by the
model numbers listed in the letter.
2. Quarantine and segregate all affected units currently in your inventory. Place affected
product in a clearly labeled quarantine area to prevent inadvertent use.
3. This notice needs to be passed on to all those who need to be aware within your
organization or facilities where the affected devices have been transferred.
4. Please retain a copy of this letter, and keep a copy of the Acknowledgement Form.
5. Complete the attached Acknowledgement Form and return it by email to
[email protected] within 2 business days.
6. InspireMD will contact each affected customer to facilitate the return and disposition process.
Root Cause
Component design/selection
Distribution Pattern
US Nationwide distribution in the states of AR, AZ, CA, DC, FL, GA, HI, IL, IN, KS, MA, MD, MI, MO, NC, NJ, NV, NY, OH, OR, RI, SD, TN, TX, VA, WA, WI, WV.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.